Fundraising Fox
/Companies
Sign in

Resalis Therapeutics

Turin, IT · 4 known investors

Find your way into Resalis Therapeutics

Each arrow is one introduction. Sign up to fill in the first one.

363 people can intro you to Riccardo

Ask Claus Andersson to introduce you to Riccardo Panella

You →Claus · together at Resalis Therapeutics →Riccardo

Sign up to find every way you can get introduced to Resalis Therapeutics

  • Your email: who you already know at Resalis Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Resalis Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Resalis Therapeutics develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders. The company is advancing RES-010, a treatment candidate for obesity, fatty liver disease, and related metabolic disorders.

BiotechHealthtechLongevityMedical Devices

Founders & leadership

RPRiccardo Panella
Riccardo PanellaChief Scientific Officer & Co-FounderRiccardo Panella is an Associate Professor at the Center for RNA Medicine at Aalborg University's Copenhagen campus and Chief Scientific Officer and co-founder of Resalis Therapeutics, which develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders.
SKSakari Kauppinen
Sakari KauppinenChief Technology Officer & Co-Founder

Investors · 4

Italian Angels for Growthlisted by Italian Angels for GrowthMilan
Sunstone CapitalreportedFrederiksberg

How we know: the VCSheet dataset · Not right? Tell us

Also in the syndicate · 1

Sunstone Life Science Ventureslead

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeries AJan 2024

    Sunstone Life Science Ventures (lead)

    Source ↗
  • Undisclosed amountSeed FinancingFeb 2023
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Resalis Therapeutics Raises €10M in Seed Financingfinsmes.com · Feb 2023

Frequently asked questions

What does Resalis Therapeutics do?
Resalis Therapeutics develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders. The company is advancing RES-010, a treatment candidate for obesity, fatty liver disease, and related metabolic disorders.
Who founded Resalis Therapeutics?
Resalis Therapeutics was founded by Riccardo Panella, Sakari Kauppinen.
Who are Resalis Therapeutics's investors?
Resalis Therapeutics's investors include Claris Ventures, Italian Angels for Growth, Sunstone Capital.
Where is Resalis Therapeutics headquartered?
Resalis Therapeutics is headquartered in Turin, IT.